000152067 001__ 152067
000152067 005__ 20250326144155.0
000152067 0247_ $$2doi$$a10.3390/jcm10143045
000152067 0248_ $$2sideral$$a126867
000152067 037__ $$aART-2021-126867
000152067 041__ $$aeng
000152067 100__ $$aCañamares-Orbís, P.
000152067 245__ $$aNew trends and advances in non-variceal gastrointestinal bleeding—series II
000152067 260__ $$c2021
000152067 5060_ $$aAccess copy available to the general public$$fUnrestricted
000152067 5203_ $$aThe gastrointestinal tract is a long tubular structure wherein any point in the mucosa along its entire length could be the source of a hemorrhage. Upper (esophagel and gastroduodenal) and lower (jejunum, ileum, and colon) gastrointestinal bleeding are common. Gastroduodenal and colonic bleeding are more frequent than bleeding from the small bowel, but nowadays the entire gastrointestinal tract can be explored endoscopically and bleeding lesions can be locally treated successfully to stop or prevent further bleeding. The extensive use of antiplatelet and anticoagulants drugs in cardiovascular patients is, at least in part, the cause of the increasing number of patients suffering from gastrointestinal bleeding. Patients with these conditions are usually older and more fragile because of their comorbidities. The correct management of antithrombotic drugs in cases of gastrointestinal bleeding is essential for a successful outcome for patients. The influence of the microbiome in the pathogenesis of small bowel bleeding is an example of the new data that are emerging as potential therapeutic target for bleeding prevention. This text summarizes the latest research and advances in all forms of acute gastrointestinal bleeding (i.e., upper, small bowel and lower). Diagnosis is approached, and medical, endoscopic or antithrombotic management are discussed in the text in an accessible and comprehensible way.
000152067 540__ $$9info:eu-repo/semantics/openAccess$$aby$$uhttp://creativecommons.org/licenses/by/3.0/es/
000152067 590__ $$a4.964$$b2021
000152067 591__ $$aMEDICINE, GENERAL & INTERNAL$$b55 / 172 = 0.32$$c2021$$dQ2$$eT1
000152067 592__ $$a1.04$$b2021
000152067 593__ $$aMedicine (miscellaneous)$$c2021$$dQ1
000152067 594__ $$a4.4$$b2021
000152067 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/publishedVersion
000152067 700__ $$0(orcid)0000-0001-5932-2889$$aLanas Arbeloa, Á.$$uUniversidad de Zaragoza
000152067 7102_ $$11007$$2610$$aUniversidad de Zaragoza$$bDpto. Medicina, Psiqu. y Derm.$$cArea Medicina
000152067 773__ $$g10, 14 (2021), 3045 [19 pp.]$$pJ. clin.med.$$tJournal of Clinical Medicine$$x2077-0383
000152067 8564_ $$s369344$$uhttps://zaguan.unizar.es/record/152067/files/texto_completo.pdf$$yVersión publicada
000152067 8564_ $$s2650879$$uhttps://zaguan.unizar.es/record/152067/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada
000152067 909CO $$ooai:zaguan.unizar.es:152067$$particulos$$pdriver
000152067 951__ $$a2025-03-26-13:54:23
000152067 980__ $$aARTICLE